Atlas Trials

An Exploratory Study to Evaluate the Safety of Brimonidine Intravitreal Implant in Patients With Retinitis Pigmentosa

Clinical trial NCT00661479 · COMPLETED

Trial details

NCT number
NCT00661479
Sponsor
Allergan
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Retinitis Pigmentosa
Start date
2008-07-01
Primary completion
2009-12-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.